Arca Biopharma reported $4.09M in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Arca Biopharma USD 4.09M 441K Mar/2025
Biogen USD 25.3M 12.6M Jun/2026
Compugen USD 1.84M 699K Jun/2026
CSL USD 18M 1000K Dec/2024
Cytokinetics USD 13.94M 2.92M Jun/2026
Daiichi Sankyo JPY 9.74B 217M Jun/2026
Gilead Sciences USD 45M 50M Jun/2026
GlaxoSmithKline GBP 58M 36M Jun/2026
Myriad Genetics USD 300K 0 Mar/2025
Otsuka Holdings JPY 199M 5.45B Sep/2026
Pfizer USD 0.56 0.6 Sep/2026
United Therapeutics USD 31.5M 10.3M Jun/2026